BioMarin Pharmaceuticalvs.United Therapeutics
BMRN vs UTHR · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
United Therapeutics is about 2.0× larger than BioMarin Pharmaceutical by market cap; United Therapeutics trades at the lower P/E (18.0 vs 42.6); year to date, United Therapeutics leads (+12.3% vs −0.5%).
Side by side
| BMRN | UTHR | |
|---|---|---|
| Market cap | $11.4B | $23.2B |
| Price | $59.12 | $547.06 |
| Today | −1.4% | −1.0% |
| Return YTD | −0.5% | +12.3% |
| Return 1Y | +0.5% | +82.3% |
| P/E | 42.6 | 18.0 |
| P/S | 3.5 | 7.3 |
| P/B | 1.8 | 3.9 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
BioMarin PharmaceuticalBMRN
Biopharma specialized in enzyme and gene therapies for rare genetic diseases.
Full BMRN profile →United TherapeuticsUTHR
Biopharma in pulmonary hypertension and organ manufacturing (xenotransplantation).
Full UTHR profile →More comparisons in Biotech & innovation
See where BMRN and UTHR sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →